Measuring response to therapy by near-infrared imaging of tumors using a phosphatidylserine-targeting antibody fragment

Molecular Imaging

Volumn 12, Issue 4, 2013, Pages 244-256

  Gong, Jian ^a,b   Archer, Richard ^a,b   Brown, Michael ^a,b   Fisher, Seth ^a,b   Chang, Connie ^a,b   Peacock, Matthew ^a,b   Hughes, Christopher ^a,b   Freimark, Bruce ^a  

^a Peregrine Pharmaceuticals Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY FRAGMENT; INNER LEAFLETS; NEAR-INFRARED IMAGING; NEAR-INFRARED OPTICAL IMAGING; PHOSPHATIDYLSERINE; POST INJECTION; THERAPEUTIC AGENTS; VASCULAR ENDOTHELIAL CELLS;

ANTIBODIES; CELL MEMBRANES; CHEMOTHERAPY; ENDOTHELIAL CELLS; INFRARED DEVICES; INFRARED IMAGING; MAMMALS; PATIENT TREATMENT; PROBES;

TUMORS;

ANTIBODY; DIAGNOSTIC AGENT; PHOSPHATIDYLSERINE;

ARTICLE; CHEMISTRY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; METHODOLOGY; NEOPLASM; NICK END LABELING;

ANTIBODIES; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IN SITU NICK-END LABELING; MALE; NEOPLASMS; PHOSPHATIDYLSERINES;

EID: 84879097219     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2012.00039     Document Type: Article

References (43)

1. Hirsch FR, Franklin WA, Gazdar AF, Bunn PA Jr. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 2001;7:5-22.
2. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-53, doi:10.1038/nm0295-149.
3. Belhocine T, Steinmetz N, Green A, Rigo P. In vivo imaging of chemotherapy-induced apoptosis in human cancers. Ann N Y Acad Sci 2003;1010.:525-9.
4. Williamson P, Schlegel RA. Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells. MolMembr Biol 1994;11:199-216, doi:10.3109/09687689409160430.
5. Balasubramanian K, Schroit AJ. Aminophospholipid asymmetry: A matter of life and death. Annu Rev Physiol 2003;65:701-34, doi:10.1146/annurev.physiol.65. 092101.142459.
6. Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 2002;62:6132-40.
7. Ran S, Thorpe PE. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiat Oncol Biol Phys 2002;54:1479-84, doi:10.1016/S0360- 3016(02)03928-7.
8. Huang X, Bennett M, Thorpe PE. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice. Cancer Res 2005;65:4408-16, doi:10.1158/0008- 5472.CAN-05-0031.
9. Stace CL, Ktistakis NT. Phosphatidic acid- and phosphatidylserinebinding proteins. Biochim Biophys Acta 2006;1761:913-26.
10. Burtea C, Laurent S, Lancelot E, et al. Peptidic targeting of phosphatidylserine for theMRI detection of apoptosis in atherosclerotic plaques. Mol Pharm 2009;6:1903-19, doi:10.1021/mp900106m.
11. Igarashi K, Kaneda M, Yamaji A, et al. A novel phosphatidylserinebinding peptide motif defined by an anti-idiotypic monoclonal antibody. Localization of phosphatidylserine-specific binding sites on protein kinase C and phosphatidylserine decarboxylase. J Biol Chem 1995;270:29075-8, doi:10.1074/jbc.270.49.29075.
12. Hanshaw RG, Smith BD. New reagents for phosphatidylserine recognition and detection of apoptosis. Bioorg Med Chem 2005; 13:5035-42, doi:10.1016/j.bmc. 2005.04.071.
13. Buehler A, Herzog E, Ale A, et al. High resolution tumor targeting in living mice by means of multispectral optoacoustic tomography. EJNMMI Res 2012;2:14, doi:10.1186/2191-219X-2-14.
14. Belhocine TZ, Blankenberg FG. 99mTc-annexin A5 uptake and imaging to monitor chemosensitivity. Methods Mol Med 2005;111: 363-80.
15. Stratton JR, Dewhurst TA, Kasina S, et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 1995;92:3113-21, doi:10.1161/01.CIR.92.10.3113.
16. Blankenberg FG, Katsikis PD, Tait JF, et al. Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med 1999; 40:184-91.
17. Beck AW, Luster TA, Miller AF, et al. Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice. Int J Cancer 2006;118:2639-43, doi:10.1002/ijc.21684.
18. Ran S, He J, Huang X, et al. Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin Cancer Res 2005;11:1551-62, doi:10.1158/1078-0432.CCR-04-1645.
19. Luster TA, He J, Huang X, et al. Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells. J Biol Chem 2006;281:29863-71, doi:10.1074/jbc.M605252200.
20. Gerber DE, Stopeck AT, Wong L, et al. Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine- targeting monoclonal antibody, in patients with advanced solid tumors. Clin Cancer Res 2011;17:6888-96, doi:10.1158/1078- 0432.CCR-11-1074.
21. Jennewein M, Lewis MA, Zhao D, et al. Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clin Cancer Res 2008;14:1377- 85, doi:10.1158/1078-0432.CCR- 07-1516.
22. Yin Y, Kavlie A, Thorpe PE. Fully human anti-phosphatidylserine antibody inhibits the growth of prostate cancer in mice. In: Proceedings for the 100th Annual Meeting of the American Association for Cancer Research; 2009; Denver, CO.
23. Zhao D, Stafford JH, Zhou H, Thorpe PE. Near-infrared optical imaging of exposed phosphatidylserine in a mouse glioma model. Transl Oncol 2011;4:355-64.
24. Mandl SJ, Mari C, Edinger M, et al. Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. Mol Imaging 2004;3:1-8, doi:10.1162/153535004773861679.
25. Belhocine T, Steinmetz N, Hustinx R, et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 2002;8:2766-74.
26. Kown MH, Strauss HW, Blankenberg FG, et al. In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin V. Am J Transplant 2001;1:270-7, doi:10.1034/j.1600-6143.2001.001003270.x.
27. Ishino S, Kuge Y, Takai N, et al. 99mTc-annexin A5 for noninvasive characterization of atherosclerotic lesions: imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits. Eur J Nucl Med Mol Imaging 2007;34:889-99, doi:10.1007/s00259-006-0289-x.
28. Narula J, Acio ER, Narula N, et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001; 7:1347-52, doi:10.1038/nm1201-1347.
29. Ingber DE, Madri JA, Folkman J. Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion. In Vitro Cell Dev Biol 1987;23:387-94, doi:10.1007/ BF02620997.
30. He J, Luster TA, Thorpe PE. Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids. Clin Cancer Res 2007;13:5211-8, doi:10.1158/1078-0432.CCR-07- 0793.
31. He J, Yin Y, Luster TA, et al. Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin Cancer Res 2009;15:6871-80, doi:10.1158/1078-0432. CCR-09-1499.
32. Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 2003;44:233-42, doi:10.1194/jlr.R200019-JLR200.
33. Zachowski A, Favre E, Cribier S, et al. Outside-inside translocation of aminophospholipids in the human erythrocyte membrane is mediated by a specific enzyme. Biochemistry 1986;25:2585-90, doi:10.1021/bi00357a046.
34. Stafford JH, Thorpe PE. Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. Neoplasia 2011;13:299-308.
35. Blankenberg F. To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy Clin Cancer Res 2002;8:2757-8.
36. Amin C, Mackman N, Key NS. Microparticles and cancer. Pathophysiol Haemost Thromb 2007;36:177-83, doi:10.1159/000175155.
37. Lechner D, Kollars M, Gleiss A, et al. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity. J Thromb Haemost 2007;5: 2445-52, doi:10.1111/j.1538-7836.2007. 02788.x.
38. Ke S, Wen X, Wu QP, et al. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V. J Nucl Med 2004;45:108-15.
39. Kemerink GJ, Liu X, Kieffer D, et al. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med 2003;44:947- 52.
40. Lub-de Hooge MN, Kosterink JG, Perik PJ, et al. Preclinical characterisation of 111In-DTPA-trastuzumab. Br J Pharmacol 2004;143:99-106, doi:10.1038/sj.bjp.0705915.
41. Blankenberg FG, Kalinyak J, Liu L, et al. 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody. Eur J Nucl Med Mol Imaging 2006;33:566-74, doi:10.1007/s00259-005-0046-6.
42. Lahorte CM, Vanderheyden JL, Steinmetz N, et al. Apoptosisdetecting radioligands: current state of the art and future perspectives. Eur J Nucl Med Mol Imaging 2004;31:887-919, doi:10.1007/s00259-004-1555-4.
43. Cauchon N, Langlois R, Rousseau JA, et al. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V. Eur J Nucl Med Mol Imaging 2007;34:247-58, doi:10.1007/s00259-006-0199-y.